Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Units: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1,332,1,133,120,67,12,
%Units according to biotechnology used: Genetic code,41,33,88,87,33,
%Units according to biotechnology used: Functional units,48,41,89,91,50,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,31,24,74,82,50,
%Units according to biotechnology used: Bioprocesses,53,50,61,93,42,
%Units according to biotechnology used: Sub-cellular organisms,14,6,56,72,33,
%Units according to biotechnology used: Bio-computing,31,24,69,85,8,
%Units according to biotechnology used: Nanobiotechnology,19,13,50,70,8,
%Units according to biotechnology used: Other,14,14,8,18,8,
Units in which biotechnology activities are:  Main and/or exclusive,647,603,33,5,6,
Units in which biotechnology activities are: A secondary line of business,252,173,39,38,2,
Units in which biotechnology activities are: A tool necessary for production,433,357,48,24,4,
%Units by field(s) of ultimate application of biotechnology use: Human health,51,45,78,91,58,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,18,15,67,8,
%Units by field(s) of ultimate application of biotechnology use: Food products,32,31,20,79,8,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,24,22,19,73,25,
%Units by field(s) of ultimate application of biotechnology use: Environment,17,14,22,72,17,
%Units by field(s) of ultimate application of biotechnology use: Industry,15,12,12,67,8,
Personnel in R&D in biotechnology (no. of persons),40,018,11,510,13,944,14,415,149,
Personnel in R&D in biotechnology (no. of persons): Researchers,26,603,6,202,8,687,11,634,80,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,13,415,5,308,5,257,2,781,69,
Personnel in R&D in biotechnology (no. of persons): women,22,240,6,389,8,590,7,165,96,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,13,936,3,304,5,040,5,545,47,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,8,305,3,086,3,550,1,620,49,
Personnel in R&D in biotechnology (FTE),27,550.6,8,236.9,10,492.6,8,726.3,94.8,
Personnel in R&D in biotechnology (FTE): Researchers,17,572.9,4,596.1,6,124.4,6,798.1,54.3,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,9,977.7,3,640.8,4,368.2,1,928.2,40.5,
Personnel in R&D in biotechnology (FTE): women,15,792.1,4,698.5,6,519.9,4,509.0,64.7,
Personnel in R&D in biotechnology (FTE): (women) Researchers,9,524.4,2,512.5,3,603.3,3,374.3,34.3,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,6,267.7,2,186.0,2,916.6,1,134.7,30.4,
Internal expenditure on R&D (thousands of euros),1,783,011,769,431,596,928,411,163,5,489,
1) By nature of the expense: Current expenses,1,673,710,719,715,567,086,381,526,5,383,
1.1) Remuneration to researchers,677,784,221,447,225,782,228,981,1,573,
1.2) Remuneration to technicians and assistants,290,584,122,809,107,902,58,884,989,
1.3) Other current expenses,705,342,375,459,233,402,93,661,2,820,
2) By nature of the expense: Capital expenses,109,301,49,715,29,842,29,637,106,
2.1) Land and buildings,18,585,9,521,3,511,5,553,0,
2.2) Equipment and instruments,78,285,30,466,25,115,22,598,106,
2.3) Acquisition of specific R+D software,4,139,1,810,1,014,1,314,1,
2.4) Otros productos de propiedad intelectual específicos para I+D,8,292,7,919,202,172,0,
1.1) By origin of the funds: Own funds,639,755,490,913,69,873,78,383,585,
1.2) By origin of the funds: From companies,189,495,82,548,77,770,28,349,828,
1.3) By origin of the funds: Public Administration funds,737,076,96,809,379,076,258,952,2,239,
1.4) By origin of the funds: From Universities,2,962,197,1,380,1,309,75,
1.5) By origin of the funds: From non profit private institutions,24,088,4,766,11,426,6,679,1,217,
1.6) By origin of the funds: Foreign funds,189,635,94,197,57,401,37,492,545,
Purchase of services R & D in Biotechnology to (thousands of euros),153,607,120,281,26,850,6,101,375,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,98,024,69,564,22,379,5,769,312,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,55,583,50,718,4,470,332,63,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,47,45,59,58,75,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,12,3,12,25,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,20,16,41,40,33,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,16,14,28,36,25,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,19,16,33,43,33,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,20,18,30,40,25,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,15,11,11,33,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,37,42,34,42,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,53,52,61,61,58,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,20,20,19,25,
%Units that have requested biotechnology patents in Biotechnology,21,15,45,75,8,
Number of patents requested,1,785,681,555,548,1,
Notes:
1) '..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Source: National Statistics Institute